Tate & Lyle agrees takeover by U.S. rival Ingredion in £2.7bn deal

Traders Union
All News
Financial News
Tate & Lyle takeover by Ingredion

Highlights

Tate & Lyle agreed to be acquired by Ingredion for £2.7bn, valuing shares at 595p plus 20p dividends—a 64% premium to pre-deal price.
Ingredion expands its portfolio and geographic reach via the acquisition, focusing on texturants, sugar reduction and fortification products.
The deal follows Tate & Lyle's underperformance and highlights mounting pressure on London's equity market as more listed firms pursue privatizations.

Deal terms and strategic rationale

As reported by Financial Times, Tate & Lyle said on Monday it had agreed to be acquired by Ingredion on terms worth 595p a share, plus dividends of 20p a share. The companies had confirmed takeover talks two weeks earlier, a disclosure that sent Tate & Lyle shares up by more than 45%.

The transaction value of 615p a share represents a 64% premium to Tate & Lyle's share price before Ingredion's interest became public. For Ingredion, the acquisition broadens its portfolio in texturants, sugar reduction and fortification products, while also adding geographic diversification.

Jim Zallie, chief executive of Ingredion, said the combined business would be better placed to meet customer demand for food products that are healthier, affordable and good-tasting. Tate & Lyle has been seeking to strengthen its position in speciality ingredients after exiting its historic sugar business in 2010 through the sale of its European operations, including Lyle's Golden Syrup, to American Sugar Refining.

Pressure on Tate and London market impact

Tate & Lyle enters the deal after a prolonged period of underperformance against investor expectations. The company has been dealing with weak consumer demand, rising costs and the spread of GLP-1 weight-loss drugs, factors that have weighed on sentiment around the business.

The takeover also adds to pressure on London's equity market, where listed companies continue to face bids and privatizations. Intertek, Beazley and Schroders have also agreed deals to go private this year, while London continues to struggle to attract large initial public offerings to replace departing companies.

In our earlier coverage of Ingredion’s takeover of Tate & Lyle, we explained how the £2.7 billion all-cash deal capped Tate & Lyle’s long shift from a legacy sugar refiner into a specialty food and beverage ingredients business. We also highlighted the company’s strategic moves in recent years—such as exiting its remaining Primient stake and buying CP Kelco—to deepen its focus on higher-growth specialty ingredients and position itself for demand in reformulated, lower-calorie products.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.